Holdings (as at 2026-04-10)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.96%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-04-10)
Security Name % of Net Assets
Moderna, Inc. 5.25%
United Therapeutics Corporation 4.18%
Axsome Therapeutics, Inc. 4.08%
Gilead Sciences, Inc. 4.06%
Alkermes Plc 3.98%
Corcept Therapeutics Inc. 3.95%
Amgen Inc. 3.81%
argenx SE (ADR) 3.59%
Exelixis, Inc. 3.56%
Krystal Biotech, Inc. 3.50%
BioNTech SE (ADR) 3.38%
Neurocrine Biosciences, Inc. 3.36%
Regeneron Pharmaceuticals, Inc. 3.33%
Vertex Pharmaceuticals Incorporated 3.33%
Halozyme Therapeutics, Inc. 3.31%
BioMarin Pharmaceutical Inc. 3.27%
Biogen Inc. 3.26%
BeOne Medicines Ltd. (ADR) 3.24%
Incyte Corporation 3.18%
Sarepta Therapeutics, Inc. 3.14%
Illumina, Inc. 3.03%
Bio-Techne Corporation 2.99%
Genmab A/S (ADR) 2.92%
Natera, Inc. 2.91%
ACADIA Pharmaceuticals Inc. 2.87%
Alnylam Pharmaceuticals, Inc. 2.86%
Veracyte, Inc. 2.62%
Repligen Corporation 2.55%
Bruker Corporation 2.44%
NeoGenomics, Inc. 2.07%
Dreyfus Government Cash Management (Institutional Shares) 0.03%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.